Connect with us and learn more about the Accellix Automated Cell Phenotyping Platform at these scientific events…
Events
Advanced Therapies Europe
September 2, 2025 – September 4, 2025
Barcelona, Spain
Through exceptional experiences we re-imagine the way the advanced therapies industry connects to change lives.
Are you encountering difficulties navigating the European market? Would you be interested in delving into strategies to overcome these obstacles alongside individuals who have firsthand experience with similar challenges? If so, Advanced Therapies Europe offers an ideal platform to explore cutting-edge innovations and glean insights from fellow industry professionals.
CAR-TCR Summit
September 23, 2025 – September 26, 2025
Boston, MA
As cell therapies continue to demonstrate transformative potential in the clinic whilst reaching new milestones for commercial success, the 10th CAR-TCR Summit is returning as the world’s leading global forum to accelerate end-to-end development of cell therapies to patients in need.
Built by industry for industry, this year’s agenda features end-to-end coverage of every stage of cell therapy development. From breakthroughs in novel engineering and armoring technologies, streamlined manufacturing to meet tight timelines, optimizing pre-clinical models to reviewing clinical data, to efficiently characterizing your cell therapy product.
Whether you’re a C-level strategic leader, or analytical scientist, you’re guaranteed to leave with actionable solutions to combat the challenges currently halting your therapeutic development and effectively translate your cell therapy from bench to bedside.
The cell therapy community is stronger together. Seize your opportunity to come together this September in an industry-focused environment to celebrate a decade of engineering a disease-free world, and solidify your impact on the future of cell therapy development in pursuit of the shared mission of bringing more life-saving therapies to patients in need.
Cell and Gene Meeting on the Mesa
October 6, 2025 – October 8, 2025
Phoenix, AZ
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.
The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
BioPharma Webinar: Potency Assays and Functional Characterisation-Going Hand-in-Hand during Product Development up to Commercial Licensing
October 22, 2025
The potency assay is a highly critical assay for cell and gene therapy products and is one of the assays on the release specification. The potency assay needs to reflect the main mechanism of action/s of the product and the CQA. Using cellular function characterisation assays during development provides critical insights which help to establish the most relevant and appropriate potency assay for the product.
Presenters: Therese Choquette at Tigen Pharma, Ulrike Herbrand at Charles River Laboratories, and Felix Montero Julian at Accellix
Sponsored by Charles River and Accellix
Register your FREE seat now!
AABB (Association for the Advancement of Blood & Biotherapies) 2025
October 25, 2025 – October 28, 2025
San Diego, CA
The AABB Annual Meeting brings together the latest research and practice-changing resources for the fields of blood and biotherapies. Colleagues from throughout the world attend to connect, network, learn and advance the field.
By actively participating in the continuing education programming at the Annual Meeting, physicians and other health care professionals should be able to:
- Disseminate the latest developments in laboratory, clinical, and administrative practices in the fields of blood and biotherapies.
- Foster conversations with colleagues to stimulate scientific research, enhance clinical practice and improve quality management to improve donor and patient safety in transfusion medicine and biotherapies.
- Evaluate state of the art innovations in transfusion medicine and biotherapies.
67th American Society of Hematology (ASH) Annual Meeting and Exposition
December 6, 2025 – December 9, 2025
Orlando, FL
With more than 18,000 members from nearly 100 countries, ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.
ASH offers premier educational and scientific meetings and workshops for hematology professionals worldwide.
